XBiotech Ownership | Who Owns XBiotech?

XBiotech Ownership Summary

XBiotech is owned by 14.74% institutional investors, 35.07% insiders, and 50.19% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 4.25% of XBIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.04% of its assets in XBiotech shares.

XBIT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	XBiotech	14.74%	35.07%	50.19%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Biotech Stocks	63.97%	10.68%	25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	1.29M	4.25%	$5.11M
Blackrock	1.13M	3.73%	$5.83M
Vanguard group	1.06M	3.49%	$4.21M
Geode capital management	454.53K	1.49%	$1.80M
Millennium management	263.52K	0.86%	$1.04M
State street	202.84K	0.67%	$1.04M
Bridgeway capital management	144.63K	0.47%	$571.29K
American century companies	124.25K	0.41%	$490.77K
Morgan stanley	100.55K	0.33%	$516.83K
Bank of new york mellon	91.06K	0.30%	$359.69K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bridgeway capital management	144.63K	0.01%	$571.29K
Thomasville national bank	13.35K	0.00%	$52.73K
Empowered funds	59.59K	0.00%	$235.38K
Connor, clark & lunn investment management	74.19K	0.00%	$293.07K
Mcilrath & eck	753.00	0.00%	$3.87K
Synovus financial	11.80K	0.00%	$46.59K
Millennium management	263.52K	0.00%	$1.04M
Tower research capital llc (trc)	4.20K	0.00%	$16.59K
American century companies	124.25K	0.00%	$490.77K
Corebridge financial	9.91K	0.00%	$39.15K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.13M	0.00%	827.52K
State street	202.84K	-	146.32K
Blackrock funding, inc. /de	1.29M	0.00%	44.12K
Ubs group	46.53K	-	32.11K
Deutsche bank ag\	30.34K	-	30.34K

Top Sellers

Holder	Shares	% Assets	Change
Ubs asset management americas	-	-	-253.77K
Hrt financial lp	-	-	-33.59K
Point72 asia (singapore) pte.	-	-	-25.95K
Price t rowe associates inc /md/	-	-	-23.63K
Bnp paribas arbitrage, snc	17.37K	-	-22.67K

New Positions

Holder	Shares	% Assets	Change	Value
Deutsche bank ag\	30.34K	-	30.34K	$119.83K
Susquehanna group, llp	12.77K	-	12.77K	$50.43K
Group one trading	7.50K	0.00%	7.50K	$29.63M

Sold Out

Holder	Change
Capital performance advisors llp	-1.00
Ifp advisors	-2.00
Smartleaf asset management	-84.00
Us bancorp \de\	-100.00
Gamma investing	-151.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	54	-	4,494,575	-4.70%	14	6.15%	18	-37.93%	21	110.00%
Dec 31, 2024	34	-30.61%	3,565,665	-26.50%	11	4.62%	18	-43.75%	6	-
Sep 30, 2024	49	4.26%	4,851,469	7.42%	15	7.23%	32	-	6	-25.00%
Jun 30, 2024	47	-2.08%	4,516,464	13.05%	14	8.61%	32	23.08%	8	-20.00%
Mar 31, 2024	48	17.07%	3,994,955	15.90%	13	10.23%	26	36.84%	10	25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	623.36K	2.04%	-
Vanguard Total Stock Mkt Idx Inv	623.36K	2.04%	-
iShares Russell 2000 ETF	443.52K	1.45%	216.00
Vanguard Institutional Extnd Mkt Idx Tr	292.55K	0.96%	-
iShares Russell 2000 Value ETF	196.83K	0.65%	-
Fidelity Small Cap Index	195.66K	0.64%	-
Fidelity Extended Market Index	109.16K	0.36%	1.58K
Vanguard Russell 2000 ETF	98.93K	0.32%	5.59K
State St Russell Sm Cap® Indx SL Cl I	90.50K	0.30%	-
Avantis US Small Cap Value ETF	71.76K	0.24%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 03, 2024	SIMARD JOHN	Chief Executive Officer	Buy	$10.00M
Oct 18, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$431.25K
Oct 15, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$226.47K
Oct 13, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$139.53K
Oct 12, 2021	SIMARD JOHN	Chief Executive Officer	Sell	$229.94K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q2	-	-
2024 Q1	1	-
2023 Q3	-	-
2023 Q2	-	-

XBIT Ownership FAQ

Who Owns XBiotech?

XBiotech shareholders are primarily institutional investors at 14.74%, followed by 35.07% insiders and 50.19% retail investors. The average institutional ownership in XBiotech's industry, Biotech Stocks , is 63.97%, which XBiotech falls below.

Who owns the most shares of XBiotech?

XBiotech’s largest shareholders are Blackrock funding, inc. /de (1.29M shares, 4.25%), Blackrock (1.13M shares, 3.73%), and Vanguard group (1.06M shares, 3.49%). Together, they hold 11.47% of XBiotech’s total shares outstanding.

Does Blackrock own XBiotech?

Yes, BlackRock owns 3.73% of XBiotech, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.83M$. In the last quarter, BlackRock increased its holdings by 827.52K shares, a 269.88% change.

Who is XBiotech’s biggest shareholder by percentage of total assets invested?

Bridgeway capital management is XBiotech’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 144.63K XBiotech shares, valued at 571.29K$.

Who is the top mutual fund holder of XBiotech shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of XBiotech shares, with 2.04% of its total shares outstanding invested in 623.36K XBiotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools